Table 1.
Relationship between MYB expression level and clinicopathological variables and in pancreatic cancer patients
| Clinical features | Characteristic | MYB high expression group | MYB low expression group | P_value |
|---|---|---|---|---|
| Status | Alive | 42 | 44 | |
| Dead | 48 | 45 | 0.825 | |
| Age | Mean (SD) | 65.7 (11.8) | 63.6 (9.9) | |
| Median [MIN, MAX] | 68 [35,85] | 64 [39,88] | 0.2 | |
| Gender | FEMALE | 42 | 38 | |
| MALE | 48 | 51 | 0.701 | |
| Race | ASIAN | 6 | 5 | |
| BLACK | 2 | 4 | ||
| WHITE | 80 | 78 | 0.678 | |
| new_tumor_event_type | Metastasis | 29 | 29 | |
| Metastasis:Recurrence | 2 | |||
| Primary | 1 | 1 | ||
| Recurrence | 9 | 11 | 0.928 | |
| Smoking | Non-smoking | 27 | 39 | |
| Smoking | 41 | 38 | 0.249 | |
| Radiation_therapy | Non-radiation | 48 | 55 | |
| Radiation | 14 | 18 | 0.936 | |
| History_of_neoadjuvant_treatment | No neoadjuvant | 90 | 88 | |
| Yes, Radiation Prior to Resection | 1 | |||
| Therapy_type | Ancillary:Chemotherapy | 8 | 6 | |
| Chemotherapy | 54 | 48 | ||
| Chemotherapy:Vaccine | 1 | |||
| Chemotherapy:Hormone Therapy | 1 | 0.992 |
* The absence of clinical data for certain samples resulted in a diminished sample size of cases exhibiting specific individual clinical characteristics, amounting to fewer than 179 instances.